You are here: Industry Insights > COVID-19

News List

American College of Lifestyle Medicine Launches Bill of Rights to Raise Awareness of Lifestyle Medicine's Role in Type 2 Diabetes Informed Consent and Treatment prnewswire
November 11, 2020
With a goal of patient empowerment, the American College of Lifestyle Medicine has announced a Type 2 Diabetes Bill of Rights to raise consumer awareness regarding patient rights to evidence-based Lifestyle Medicine therapeutic approaches as a ...
UK study will evaluate aspirin as a potential COVID-19 treatment pharmatimes
November 11, 2020
Researchers from the UK’s RECOVERY study will evaluate the standard painkiller aspirin as a potential treatment for COVID-19 patients.
Exagen to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection americanpharmaceuticalreview
November 11, 2020
Exagen announced a new study in collaboration with Brigham and Women’s Hospital in Boston, MA. This study will evaluate the incidence and risk factors for onset of rheumatic autoimmune diseases in people who recovered from COVID-19.
Pfizer, BioNTech Announce COVID-19 Vaccine Demonstrates Efficacy in Phase 3 Analysis americanpharmaceuticalreview
November 11, 2020
Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy ...
FDA grants EUA for Lilly’s monoclonal antibody for Covid-19 treatment pharmaceutical-technology
November 11, 2020
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Eli Lilly and Company’s monoclonal antibody, bamlanivimab (LY-CoV555) 700mg, to treat patients recently diagnosed with Covid-19.
Indian researchers develop vaccine strategies for SARS-CoV-2, HIV viruses pharmaceutical-technology
November 11, 2020
Researchers at Indian Institute of Science’s (IISc) Molecular Biophysics Unit have announced the development of effective vaccine strategies against the SARS-CoV-2 and HIV viruses that cause Covid-19 and AIDS, respectively.
Novavax Expands Facility to Support Global Vaccine Development contractpharma
November 11, 2020
Expands campus with two properties to support vaccine research and development, manufacturing, business operations.
Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData expresspharma
November 11, 2020
Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months.
AbCellera antibody gets US FDA EUA as monotherapy for COVID-19 treatment expresspharma
November 11, 2020
AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to high-risk patients.
Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements expresspharma
November 11, 2020
Rajarshi Datta, Country Head & General Manager – South Asia, Honeywell Advanced Materials informs there is a growing need for new packaging technologies that allow the pharma industry to launch drugs to market faster while reducing operational costs and..